284 related articles for article (PubMed ID: 3306379)
1. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
[TBL] [Abstract][Full Text] [Related]
2. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
4. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
5. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of Haemophilus influenzae B-diphtheria conjugate vaccination in German children].
Zielen S; Scheurer J; Rhodius U; Schäfer V; Isenberg H; Bauscher P; Schröder S; Ahrens P; Hofmann D
Monatsschr Kinderheilkd; 1992 Dec; 140(12):852-6. PubMed ID: 1491705
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
[TBL] [Abstract][Full Text] [Related]
10. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
11. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
Bewley KM; Schwab JG; Ballanco GA; Daum RS
Pediatrics; 1996 Nov; 98(5):898-904. PubMed ID: 8909483
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
Weinberg GA; Murphy TV; Granoff DM
Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
[No Abstract] [Full Text] [Related]
13. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
14. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
15. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
Peltola H; Käyhty H; Sivonen A; Mäkelä H
Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
Käyhty H; Peltola H; Eskola J
Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
